CPA
AGN

Capital Planning Advisors’s Allergan plc AGN Stock Holding History

Capital Planning Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-9,949
Closed -$2.04M – 132
2017
Q3 		$2.04M Sell
9,949
-725
-7% -$169K 0.8% 40
2017
Q2 		$2.6M Buy
10,674
+7,000
+191% +$1.64M 1.15% 26
2017
Q1 		$878K Buy
3,674
+1,625
+79% +$378K 0.43% 56
2016
Q4 		$430K Sell
2,049
-1,269
-38% -$263K 0.23% 74
2016
Q3 		$764K Buy
3,318
+765
+30% +$187K 0.41% 56
2016
Q2 		$590K Buy
+2,553
New +$589K 0.33% 61

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Capital Planning Advisors's AGN Position: Q4 2017 in Review

Capital Planning Advisors sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 9,949 shares — an estimated $2.04M sold.

Capital Planning Advisors first reported a position in AGN in Q2 2016 and held it in 6 quarters. The position peaked at $2.6M in Q2 2017. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • Capital Planning Advisors reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • Capital Planning Advisors sold 9,949 Allergan plc shares in Q4 2017, an estimated $2.04M.
  • Capital Planning Advisors first reported a position in Allergan plc in Q2 2016 and held it in 6 quarters.
  • Capital Planning Advisors's Allergan plc position peaked at $2.6M in Q2 2017.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Capital Planning Advisors's 13F filing for Q4 2017, filed 8 Feb 2018.